Fort Washington Investment Advisors Lowered Its Celgene (CELG) Stake; Milacron Holdings Corp. (MCRN) Covered By 5 Bulls

May 27, 2018 - By Mary Manson

Celgene Corporation (NASDAQ:CELG) Logo

Among 7 analysts covering Milacron Holdings Corp (NYSE:MCRN), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Milacron Holdings Corp had 15 analyst reports since August 4, 2015 according to SRatingsIntel. KeyBanc Capital Markets maintained the stock with “Buy” rating in Friday, February 23 report. KeyBanc Capital Markets initiated Milacron Holdings Corp. (NYSE:MCRN) on Tuesday, August 4 with “Overweight” rating. Barclays Capital initiated it with “Overweight” rating and $25 target in Tuesday, August 4 report. Robert W. Baird initiated the shares of MCRN in report on Tuesday, August 4 with “Outperform” rating. The stock has “Outperform” rating by William Blair on Tuesday, August 4. Robert W. Baird maintained Milacron Holdings Corp. (NYSE:MCRN) on Friday, November 10 with “Buy” rating. On Wednesday, October 4 the stock rating was maintained by Robert W. Baird with “Buy”. KeyBanc Capital Markets maintained it with “Buy” rating and $21.0 target in Friday, September 15 report. The stock of Milacron Holdings Corp. (NYSE:MCRN) earned “Buy” rating by Bank of America on Tuesday, August 4. The firm has “Neutral” rating given on Tuesday, August 4 by JP Morgan. See Milacron Holdings Corp. (NYSE:MCRN) latest ratings:

23/02/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $24.0 Maintain

Fort Washington Investment Advisors Inc decreased Celgene Corp (CELG) stake by 6.93% reported in 2017Q4 SEC filing. Fort Washington Investment Advisors Inc sold 5,412 shares as Celgene Corp (CELG)’s stock declined 19.30%. The Fort Washington Investment Advisors Inc holds 72,631 shares with $7.58M value, down from 78,043 last quarter. Celgene Corp now has $57.11B valuation. The stock decreased 1.14% or $0.91 during the last trading session, reaching $78.63. About 4.78 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since May 27, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: which released: “Goldman bearish on Celgene” on May 25, 2018, also with their article: “Will ‘Public Shaming’ Sink Celgene?” published on May 21, 2018, published: “Best And Worst Performing Nasdaq 100 Stocks Of 2018” on May 25, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: and their article: “Celgene: Still (Looks) Appealing” published on May 21, 2018 as well as‘s news article titled: “Is Celgene’s Stock A Buy The Dip Opportunity?” with publication date: May 23, 2018.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 20 have Buy rating, 1 Sell and 14 Hold. Therefore 57% are positive. Celgene Corporation had 149 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Leerink Swann on Monday, May 7. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Friday, October 20 by Cowen & Co. On Wednesday, June 1 the stock rating was downgraded by BTIG Research to “Neutral”. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Monday, January 8 by BMO Capital Markets. The rating was maintained by UBS with “Buy” on Friday, November 6. The firm has “Buy” rating by Canaccord Genuity given on Thursday, July 27. RBC Capital Markets downgraded it to “Outperform” rating and $118 target in Monday, May 7 report. On Wednesday, November 9 the stock rating was downgraded by Standpoint Research to “Hold”. The rating was initiated by Jefferies with “Buy” on Monday, July 10. UBS maintained Celgene Corporation (NASDAQ:CELG) on Friday, October 27 with “Buy” rating.

Fort Washington Investment Advisors Inc increased Novartis Ag (NYSE:NVS) stake by 93,988 shares to 1.76M valued at $148.16 million in 2017Q4. It also upped Priceline Group Inc. (NASDAQ:PCLN) stake by 10,911 shares and now owns 57,964 shares. Procter & Gamble Co (NYSE:PG) was raised too.

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.34, from 1.17 in 2017Q3. It worsened, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Reilly Advsr Limited Liability has invested 0.02% of its portfolio in Celgene Corporation (NASDAQ:CELG). First Heartland Consultants owns 0.08% invested in Celgene Corporation (NASDAQ:CELG) for 2,514 shares. St Germain D J Com Inc accumulated 11,584 shares. Principal Gp Incorporated Inc owns 0.14% invested in Celgene Corporation (NASDAQ:CELG) for 1.41M shares. First Comml Bank Of Omaha invested in 0.62% or 100,345 shares. Td Asset Management Incorporated accumulated 471,536 shares. 278,200 were accumulated by Honeywell Intl. Gibraltar Capital Mngmt reported 46,029 shares stake. Kcm Advsrs Ltd Liability Corporation has invested 0.02% in Celgene Corporation (NASDAQ:CELG). Eastern Bankshares has 149,103 shares. Farmers Comml Bank accumulated 100 shares. Valley Advisers invested in 8,016 shares or 0.29% of the stock. North American Mngmt Corporation stated it has 9,952 shares or 0.16% of all its holdings. Kentucky Retirement reported 48,551 shares or 0.36% of all its holdings. Hartwell J M Lp stated it has 7,350 shares.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on July, 26. They expect $1.87 earnings per share, up 11.31% or $0.19 from last year’s $1.68 per share. CELG’s profit will be $1.36B for 10.51 P/E if the $1.87 EPS becomes a reality. After $1.61 actual earnings per share reported by Celgene Corporation for the previous quarter, Wall Street now forecasts 16.15% EPS growth.

Since February 8, 2018, it had 2 buys, and 3 sales for $3.48 million activity. LOUGHLIN JAMES J also sold $851,093 worth of Celgene Corporation (NASDAQ:CELG) shares. KAPLAN GILLA also sold $1.77M worth of Celgene Corporation (NASDAQ:CELG) on Thursday, February 15. $1.26M worth of Celgene Corporation (NASDAQ:CELG) was sold by MARIO ERNEST on Friday, February 23. Alles Mark J also bought $299,594 worth of Celgene Corporation (NASDAQ:CELG) shares.

Another recent and important Milacron Holdings Corp. (NYSE:MCRN) news was published by which published an article titled: “Analysis: Positioning to Benefit within PTC, Black Hills, Mack-Cali Realty, Milacron, Rexahn Pharmaceuticals, and …” on May 03, 2018.

Milacron Holdings Corp. manufactures, distributes, and services engineered and customized systems within the plastic technology and processing industry in the United States and internationally. The company has market cap of $1.40 billion. The firm operates through three divisions: Advanced Plastic Processing Technologies , Melt Delivery and Control Systems (MDCS), and Fluid Technologies (Fluids). It has a 1242.5 P/E ratio. The APPT segment designs, makes, and sells injection molding, blow molding, and extrusion equipment; and auxiliary systems and related parts and service.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: